FOLFOXIRI and bevacizumab in patients with early-onset metastatic colorectal cancer. A pooled analysis of TRIBE and TRIBE2 studies

A comprehensive framework for early-onset colorectal cancer research

(2022) Cathy Eng et al.   LANCET ONCOLOGY

Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study

(2021) Carlotta Antoniotti et al.   EUROPEAN JOURNAL OF CANCER

A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers

(2021) Andrea Cercek et al.   JNCI-Journal of the National Cancer Institute

Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

(2020) Chiara Cremolini et al.   LANCET ONCOLOGY

Patient-Related Risk Factors for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review

(2020) Abu Saleh Mohammad Mosa et al.   Frontiers in Pharmacology

Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer

(2020) Chiara Cremolini et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types

(2019) Feng Wang et al.   JAMA Oncology

Impact of age and gender on the safety and efficacy of chemotherapy plus bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies

(2019) F Marmorino et al.   ANNALS OF ONCOLOGY

Early-onset colorectal cancer in young individuals

(2018) Gianluca Mauri et al.   Molecular Oncology

Overtreatment of Young Adults With Colon Cancer

(2015) Peter J. Kneuertz et al.   JAMA Surgery

Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer

(2014) Fotios Loupakis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: Clinical significance

(2009) Masaaki Iwatsuki et al.   INTERNATIONAL JOURNAL OF CANCER

Colorectal carcinoma in children and adolescents: The experience of the Istituto Nazionale Tumori of Milan, Italy

(2007) Andrea Ferrari et al.   PEDIATRIC BLOOD & CANCER